Kleo Pharmaceuticals
New Haven, US · Founded 2015 · Delaware corporation · 1 known investors
Founders & leadership
Kleo Pharmaceuticals was founded in 2015 by David Spiegel.
DS
David SpiegelFounder
DM
Douglas ManionExecutive
RP
Roy PriebNamed on SEC filing
DD
Declan DooganNamed on SEC filing
CG
Charles G. DrakeNamed on SEC filing
Board
JW
John W. ChildsBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$34.7M disclosed across 2 rounds · 2016–2018
▶$21.2MraisedJan 2019 · 19 investors · PharmaceuticalsRule 506(b)
▶$21.2MraisedJan 2019 · 19 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Douglas ManionExecutive Officer, Director
- Charles G. DrakeDirector
- Declan DooganDirector
- Roy PriebExecutive Officer, Director
- Alexander GoorDirector
- John W. ChildsDirector
- Offering amount
- $21.2M
- Amount sold
- $21.2M
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$13.5MraisedMay 2018 · 11 investors · PharmaceuticalsRule 506(b)
▶$13.5MraisedMay 2018 · 11 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Roy PriebExecutive Officer, Director
- John W. ChildsDirector
- Declan DooganDirector
- Charles G. DrakeDirector
- Douglas ManionExecutive Officer
- David SpiegelExecutive Officer, Director
- Amount sold
- $13.5M
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Kleo Pharmaceuticals?
- Kleo Pharmaceuticals was founded by David Spiegel in 2015.
- Who are Kleo Pharmaceuticals's investors?
- Kleo Pharmaceuticals's investors include Connecticut Innovations.
- How much funding has Kleo Pharmaceuticals raised?
- Kleo Pharmaceuticals has disclosed $34.7M raised across 2 rounds.
- Where is Kleo Pharmaceuticals headquartered?
- Kleo Pharmaceuticals is headquartered in New Haven, US.